Clinical Effects of Administering Leukemia-Specific Donor T Cells to Patients With AML/MDS After Allogeneic Transplant
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clinical Effects of Administering Leukemia-Specific Donor T Cells to Patients With AML/MDS Post-Allogeneic Transplant
Blood 2020 Dec 03;[EPub Ahead of Print], P Lulla, S Naik, S Vasileiou, I Tzannou, A Watanabe, M Kuvalekar, S Lulla, G Carrum, CA Ramos, R Kamble, LC Hill, JK Randhawa, S Gottschalk, R Krance, W Tao, M Wu, C Robertson, AP Gee, BM Chung, B Grilley, M Brenner, H Heslop, JF Vera, AM LeenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.